J Cancer 2019; 10(9):2102-2108. doi:10.7150/jca.28377 This issue

Research Paper

Impact of Age on Risk of Lymph Node Positivity in Patients with Colon Cancer

Haolu Wang1,2*, Hao Lu3*, Haotian Yang1, Xianwen Zhang3, Erik W. Thompson4, Michael S. Roberts1,5, Zhiqian Hu3, Xiaowen Liang1,3, Xinxing Li3✉

1. Therapeutics Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Australia
2. Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
3. Department of General Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China
4. Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia
5. School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia
*These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Wang H, Lu H, Yang H, Zhang X, Thompson EW, Roberts MS, Hu Z, Liang X, Li X. Impact of Age on Risk of Lymph Node Positivity in Patients with Colon Cancer. J Cancer 2019; 10(9):2102-2108. doi:10.7150/jca.28377. Available from https://www.jcancer.org/v10p2102.htm

File import instruction


Background: Lymph node (LN) positivity is a prognostic indicator in patients with colon cancer regardless of age, and age is an important parameter that impacts therapeutic recommendations. But little is known about the impact of age on LN positivity in patients with colon cancer.

Methods: We analyzed 257,334 patients with colon cancer diagnosed from SEER database. Logistic regression was used to examine the association of age and LN positivity. Poisson regression was used to evaluate whether age was associated with the number of positive LNs.

Results: LN positivity was inversely associated with age (P < .001 for each T stage). Age was predictive of LN positivity after adjustment for number of LNs examined and other covariates (P < .001 for each T stage). Adjusted odds ratios (ORs) for LN positivity for age 20 to 39 vs 80+ were 3.06 for stage T1 (95 % CI, 2.09 to 4.48), 2.46 for stage T2 (95 % CI, 2.00 to 3.02), 1.77 for stage T3 (95 % CI, 1.62 to 1.93), and 1.68 for stage T4 (1.51 to 1.86). Young age was a significant predictor of an increased number of positive LNs (P < .005 for each T stage).

Conclusion: Young age at diagnosis is associated with an increased risk of LN positivity. LN examination and resection could aid younger patients more with detection and removal of metastasis. Guidelines that define postdetection interventions may be needed to limit the overtreatment of older patients, who may be vulnerable to unnecessary tests and treatments.

Keywords: age, lymph node, positivity, colon cancer, prognosis